Linezolid in VAP by MRSA: a better choice?
Ioanas
Malina
M
Lode
Hartmut
H
D000081:Acetamides / Q000494:pharmacology / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D003428:Cross Infection / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D000069349:Linezolid; D016106:Methicillin Resistance / Q000502:physiology; D023303:Oxazolidinones / Q000494:pharmacology / Q000627:therapeutic use*; D011023:Pneumonia, Staphylococcal / Q000188:drug therapy* / Q000209:etiology; D012121:Respiration, Artificial / Q000009:adverse effects; D014640:Vancomycin / Q000494:pharmacology / Q000627:therapeutic use
D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D014640:Vancomycin; D000069349:Linezolid